(Q43142540)

14 November 2017

title

Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes (English)

1 reference

14 November 2017

1 reference

1 reference

1 reference

Hermes Florez

1

1 reference

14 November 2017

Jiacong Luo

2

1 reference

14 November 2017

Sumaya Castillo-Florez

3

1 reference

14 November 2017

Georgia Mitsi

4

1 reference

14 November 2017

John Hanna

5

1 reference

14 November 2017

Leonardo Tamariz

6

1 reference

14 November 2017

Ana Palacio

7

1 reference

14 November 2017

Sukumar Nagendran

8

1 reference

14 November 2017

Michael Hagan

9

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

14 November 2017

published in

Postgraduate Medicine

1 reference

14 November 2017

volume

122

1 reference

14 November 2017

issue

2

1 reference

14 November 2017

page(s)

112-120

1 reference

Diabetes, depression, and quality of life: a population study.

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Quality of life in a US national sample of adults with diabetes and motility-related upper gastrointestinal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Ondansetron and Metformin-Induced Gastrointestinal Side Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Measurement of health status. Ascertaining the minimal clinically important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Comparing SF-6D and EQ-5D utilities across groups differing in health status

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Medication taking and diabetes: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.03.2128

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.03.2128

1 reference

14 November 2017

1 reference